2023 Program

This year leadership is trying something new to allow for more opportunities to network and a stronger showcase of GA companies. The event will be more intimate and limited to approximately 350 professionals from across Georgia, the Southeast and beyond.

8:00 - 10:00 AM

Badge Pickup & Exhibit Setup

9:00 - 10:00 AM

Georgia Life Sciences Showcase

Hear Georgia-based companies who are developing or have bioscience/medtech related products present their technology.

10:00 - 11:00 AM

Plenary Session

More details coming soon

11:00 AM - 12:00 PM

Plenary: Putting the Tech in Bio/MedTech: The Intersection of Software and Science

Georgia is a global leader in software and data sciences as well as next generation life science fields such as cell therapy, protein engineering, and antibody therapeutics. The convergence of life and data sciences promises to dramatically accelerate the pace of innovation and drug development. Georgia is emerging as a leader in combining these fields to address some of the most challenging problems in life sciences. Hear from leaders building the next generation of companies at the intersection of AI/ML, computational biology, and life sciences.

Speakers

Patricia Obermaier, Chief Growth Officer, Global Health and Life Sciences, Microsoft
More coming soon
Moderator: Dr. Joe Sutherland, Director, Center for AI Learning, Emory University

12:00 - 1:30 PM

Networking Lunch / Exhibit Hall

1:30 - 3:00 PM

Plenary: Dr. Ted W. Love, Former President & CEO of Global Blood Therapeutics; 2023-2025 Board Chair, Biotechnology Innovation Organization

Announcement of Scientific Poster Session Winners
Presentation & Fireside Chat with Dr. Ted Love

3:00 - 4:00 PM

Networking / Exhibit Hall

Georgia Life Sciences
Showcase - Fast Pitch Showdown

More details coming soon

4:00 - 5:15 PM

Plenary: Launching and Funding a Company in a Challenging Environment: Investors' Perspectives of Best Practices and Critical Errors

Launching a life science company requires thousands of “make it or break it” decisions around developing the science, building the team, and financing the business. Additionally, we have gone from one of the strongest environments to one of the more challenging. This panel of seasoned investors will discuss best practices and critical errors companies make in building a capital stack from founding through acquisition as well as how those decisions influence an investor’s interest in investing at each stage and the impact on the company’s valuation. This panel will also dive into how the funding landscape for life science companies has transformed dramatically over the past 24 months.
Powered by Life Sciences Nation